Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
01/2005
01/06/2005WO2005000042A1 Composition containing lactic acid bacterium producing equol
01/06/2005WO2005000034A2 Lactic bacteria and its use in direct-fed microbials
01/06/2005WO2005000032A1 Method for treatment of sores and lesions of the skin
01/06/2005WO2004104491A3 Percussively ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
01/06/2005WO2004098285A3 Cryopreservation of human blastocyst-derived stem cells by use of a closed straw vitrification method
01/06/2005WO2004093890A8 Pharmaceutical composition comprising bioelement (enzyme and factor)
01/06/2005WO2004080175B1 Scaffold for cell growth and differentiation
01/06/2005WO2003041654A3 Anti-estrogen and immune modulator combinations for treating breast cancer
01/06/2005WO2002074234A3 Method and composition for treatment of skeletal dysplasias
01/06/2005US20050005312 Propagation of human hepatocytes in non-human animals
01/06/2005US20050004428 Cardiac disease treatment and device
01/06/2005US20050004352 Single-chain multiple antigen-binding molecule, its preparation and use
01/06/2005US20050004037 Osteogenic growth oligopeptides as stimulants of hematopoiesis
01/06/2005US20050004036 Using angiotensin peptides; therapy for ulcer caused by allergens, human immunodeficiency virus, herpes virus infections; stresses; traumas
01/06/2005US20050004006 Using transferrins as tool in reducing concentration of serum glucose, blood pressure, obesity or glycosylated hemoglobins; antidiabetic agents
01/06/2005US20050003537 Composition and method for production of transformed cells
01/06/2005US20050003531 Isolating and generating postmitotic neurons from embryonic spinal cord tissue that are capable of multiple neuronal phenotypes for use in treatment and prevention of nervous system disorders
01/06/2005US20050003529 Stem cells and method of separating the same
01/06/2005US20050003473 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
01/06/2005US20050003472 Process for the staining of sperm
01/06/2005US20050003460 Identifying progenitor cell populations comprising at least one disaccharide repeat of glucuronic acid and n-acetylglucosamine and enhanced hyaluronic acid synthase expression for use in tissue repair and treatment and prevention of cancer and/or skin disorders.
01/06/2005US20050003451 Immunoglobulin for use in diagnosis, prevention and treatment of infection, autoimmune, inflammatory and cell proliferative diseases; immunotherapy
01/06/2005US20050003431 Monovalent, multivalent, and multimeric MHC binding domain fusion proteins and conjugates, and uses therefor
01/06/2005US20050003017 Hypotensive and hypertensive properties of renomedullar extracts
01/06/2005US20050002988 Nutritional composition for controlling blood sugar level
01/06/2005US20050002949 Prevention and treatment of irritable bowel syndrome
01/06/2005US20050002944 Chlamydia antigens and corresponding DNA fragments and uses thereof
01/06/2005US20050002921 Containing lactococcus lactis, lactobacillus lactis and/or lactobacillus brevis; reducing diaherrea, improving performance; healthy dairy calves
01/06/2005US20050002920 Collecting, activating, culturing and optionally expanding peripheral blood mononuclear cells then hypomethylating with 5-aza-cytidine or 5-aza-2'-deoxycytidine
01/06/2005US20050002919 Using modified cells for drug, diagnostic agent and/or toxin delivery to target tissues; novel genetically altered human progenitor cells
01/06/2005US20050002915 Enhancement of angiogenesis to grafts using cells engineered to produce growth factors
01/06/2005US20050002914 Mesenchymal stem cells as a vehicle for ion channel transfer in syncytial structures
01/06/2005US20050002909 Methods and compositions for treating intervertebral disc degeneration
01/06/2005US20050002908 Method for producing a recombinant adeno-associated virus, suitable means therefor and use for producing a medicament
01/06/2005US20050002906 Preferentially amplifying in tumors following cancer cell activation of specific gene regulatory region
01/06/2005US20050002904 Uses of vascular endothelial growth factor and type I collagen inducible protein (VCIP)
01/06/2005US20050002884 Essential oil, petroleum jelly, lecithin and water; repairing damage; soft feel, lustrous appearance
01/06/2005US20050002874 Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
01/06/2005CA2531058A1 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus
01/06/2005CA2531017A1 Composition for external use
01/06/2005CA2530631A1 Use of bacilli-class bacteria to produce a composition for the prevention of vertebral compression syndrome in salmonids
01/06/2005CA2530422A1 Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
01/06/2005CA2530255A1 Soft tissue repair and regeneration using postpartum-derived cells
01/06/2005CA2529943A1 Peptides derived from the protein mmp-2, and the use thereof in antitumoral immunotherapy
01/06/2005CA2529941A1 Method for identification of tr1 lymphocytes regulators by the presence and overexpression of specific molecules and application thereof
01/06/2005CA2529143A1 Methods of producing neurons
01/06/2005CA2525596A1 Allogeneic cell therapy: mirror effect
01/05/2005EP1493459A1 System and method for separation of particles
01/05/2005EP1493444A1 Pharmaceutical composition used as anti-infective of the upper respiratory tract
01/05/2005EP1493432A1 In vivo method of obtaining cell components
01/05/2005EP1492869A1 Transplant acceptance inducing cells of monocytic origin and their preparation and use
01/05/2005EP1492868A2 Method of modulating inflammatory response
01/05/2005EP1492817A2 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases
01/05/2005EP1492565A2 Methods and pharmaceutical compositions for dopaminergic modulation of t-cell adhesion and acitivty
01/05/2005EP1492549A1 Compositions and methods for augmenting kidney function
01/05/2005EP1492415A2 Method of improving absorption of vitamin e by a pet animal
01/05/2005EP1492414A2 Method and dietary composition for improving fat digestibility
01/05/2005EP1492413A2 Method and dietary composition for improving lipid digestibility
01/05/2005EP1423504A4 Compositions and methods for isolation, propagation, and differentiation of human stem cells and uses thereof
01/05/2005EP1393067A4 Encapsulated cell indicator system
01/05/2005EP1290141A4 Methods of differentiating and protecting cells by modulating the p38/mef2 pathway
01/05/2005EP1152773B1 Methods of inactivating pathogens using broad-spectrum pulsed light
01/05/2005DE19957065B4 Screening-Verfahren für Arzneistoffe A screening method for drugs
01/05/2005DE10329839A1 Use of artificial nutrition solutions to treat skin diseases, especially psoriasis, neurodermatitis, acne, dermatoses or eczema
01/05/2005DE10326187A1 Zellen als Träger für Bakterien Cells as carriers for bacteria
01/05/2005CN1561388A Generation of fully mature and stable dendritic cells from leukaphereses products for clinical applications
01/05/2005CN1561387A Probiotic bifidobacterium strains
01/05/2005CN1561344A Angiogenesis-inhibitory tripeptides, compositions and their methods of use
01/05/2005CN1561232A Therapeutic agent comprising a B-subunit of a protein toxin
01/05/2005CN1561231A Inhibition of neonatal hyperbilirubinemia in breast fed infants
01/05/2005CN1561221A Novel medicinal herbal composition for treating liver diseases and HIV
01/05/2005CN1561217A Estrogen/gestagen combination preparation and application thereof
01/05/2005CN1561206A Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction
01/05/2005CN1561197A Method for producing biologically active products
01/05/2005CN1560261A Production process of whole silkworm chrysalis powder containing lactoferrbumin and its peptide
01/05/2005CN1560080A Corpuscles of stannius protein, stanniocalcin
01/05/2005CN1559495A Deer's fetus granular Chinese madicinal preparation and its production technology
01/05/2005CN1559449A Method for preparing oral liquid for treating prematophagoides farnae
01/05/2005CN1559448A Traditional Chinese medicine for treating tuberculosis, and its prepn. method
01/05/2005CN1559447A Extracte of Aspongopus chinensis Dallas and Extraction method therefor medicinal use and preparn. thereof
01/05/2005CN1559446A Antimicrobial (tincture)medicine with functons of analgesia, hemostasis and relieving-itching
01/05/2005CN1559445A Antimicrobial (aqua)medicine with functions of analgesia, hemostasis and reliveing-itching
01/05/2005CN1559444A Oral liquid contg. extration of sturgeon and sturgeon active protein capsule, prepn. method therefor
01/05/2005CN1559443A Sturgeon chondroition capsule and instant granula prepn. method therefor
01/05/2005CN1559442A Soft capsule of dried oviduct fat of forest frog
01/05/2005CN1559441A Method for preparing immune milk anti-pathogenic microoganism in digestive tract
01/05/2005CN1559440A Low-temp freezing method for storing sperm of gayal
01/05/2005CN1183250C Virus with specigic reproduction in tumor well and effective expression of tumor angiogenesis nihibitory factor and its construction method
01/05/2005CN1183247C Membrane destroyed freeze-bried spermatozoa or sperm head and its making method
01/05/2005CN1183157C Method for distillig active protein liquid of scorpion
01/05/2005CN1182863C Chinese herbal medicine for enhancing immunity
01/05/2005CN1182859C Externally applied Chinese medicine for treating trauma and its prepn.
01/04/2005US6838446 Anticancer agents; genetic engineered enzyme
01/04/2005US6838444 Using nucleic acid; repair interior ear hair
01/04/2005US6838428 A non-human mammal phenotype, vectors expressing the protein for treating respiratory system disease, viral diseases, purifying SP-D antibodies, enzyme inhibitor of metalloproteinase
01/04/2005US6838281 Cells expressing fusion proteins of immunoglobulins
01/04/2005US6838084 For connection with major histomcompatability complex molecules
01/04/2005CA2332406C Treatment of neuromuscular disorders and conditions with different botulinum serotype
01/04/2005CA2217322C Inhibition of complement pathway by sea cucumber fractions
12/2004
12/30/2004US20040268424 tissues, organs and cells for use in xenotransplantation